F-star

From Wikipedia, the free encyclopedia
Jump to: navigation, search
F-star Biotechnology Ltd.
Industry Pharmaceutical
Headquarters Cambridge, UK
Website www.f-star.com

F-star Biotechnology Ltd. is a biotechnology company originally founded in Vienna, with a current main research site in Cambridge, UK. The company is focused in developing bispecific monoclonal antibodies using a modular combinatorial approach that engineers the Fc constant region of an immunoglobulin into a novel antigen-binding site.[1][2]

See also[edit]

  1. ^ http://www.f-star.com
  2. ^ Wozniak-Knopp G, Bartl S, Bauer A, Mostageer M, Woisetschläger M, Antes B, Ettl K, Kainer M, Weberhofer G, Wiederkum S, Himmler G, Mudde GC, Rüker F. (2010). "Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.". Protein Eng Des 23 (4): 289–297. doi:10.1093/protein/gzq005. PMID 20150180.